Alicia Hong focuses her practice on China-related corporate transactions in the life sciences industry. She advises on cross-border mergers and acquisitions, licensing, strategic alliances and public listings, as well as joint venture, technology transfer and other collaboration projects. Alicia has extensive experience in facilitating transactions between European, US and Asian companies, drawing on her extended network of contacts in China including international pharma or biotech companies, PE and VC funds, state-owned enterprises and domestic private companies.
Prior to joining McDermott, Alicia has worked for other international law firms in Shanghai and Frankfurt.
* Matter handled prior to joining McDermott